Table 3.

Maximum Possible Duration of Inhaled Antiinflammatory Medication Use During 3 Months After Asthma Exacerbation, 5 to 17 Years of Age

Enrollee-yearsDuration of Inhaled Antiinflammatory Use*
Using for 2–3 MonthsMean Duration
(Maximum Possible 12 Months)Coefficient (SE)P Value
After asthma hospitalization32954.11.5
 Sex
  Female13055.41.5—Reference—
  Male19953.31.5−0.06  (0.14).67
 Age
  5–9 y18252.81.4—Reference—
  10–17 y14755.81.60.14  (0.14).32
 Period§
  1984–19865028.00.8—Reference—
  1987–199011143.21.20.36  (0.21).09
  1991–199316869.11.91.07  (0.20)<.001
After second oral  corticosteroid fill 74964.01.8
 Sex
  Female27164.91.8—Reference—
  Male47863.41.8−0.02  (0.10).87
 Age
  5–9 y33266.31.9—Reference—
  10–17 y41762.11.7−0.12  (0.09).19
 Period
  1984–198611956.31.6—Reference—
  1987–199023462.41.80.14  (0.14).33
  1991–199339667.21.90.25  (0.13).06
  • * Based on the months that filled inhaled antiinflammatory medication would last if used consecutively and completely at the minimum recommended dose. Maximum, 3 months.

  • Percent of eligible enrollees filling medication sufficient for 2–3 months of use per year.

  • Regression coefficients represent the difference in duration in months of inhaled antiinflammatory medication compared with the reference group.

  • § Use determined for each enrollee-year and presented for 3– or 4–year period.

  • Includes patients with ≥2 β-agonists prescriptions during year; patients with hospitalization during 30 days before or after second steroid fill were excluded.